Catheter Precision (VTAK) Net Cash Flow (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Catheter Precision | 2.01 Mn | 1.20 Mn | 390,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 135.79% |
| Dec 31, 2025 | -518.14% |
| Sep 30, 2025 | -32.29% |
| Jun 30, 2025 | 114.68% |
| Mar 31, 2025 | -248.60% |
| Dec 31, 2024 | 28.19% |
| Sep 30, 2024 | 184.88% |
| Jun 30, 2024 | 28.88% |
| Mar 31, 2024 | -2.98% |
| Dec 31, 2023 | -9.99% |
| Sep 30, 2023 | 61.92% |
| Jun 30, 2023 | -32.05% |
| Mar 31, 2023 | -265.35% |
| Dec 31, 2022 | -12.93% |
| Sep 30, 2022 | 138.76% |
| Jun 30, 2022 | -350.25% |
| Mar 31, 2022 | 146.80% |
| Dec 31, 2021 | -1,506.82% |
| Sep 30, 2021 | -90.72% |
| Jun 30, 2021 | 153.65% |
| Mar 31, 2021 | 18.36% |
| Dec 31, 2020 | -328.32% |
| Sep 30, 2020 | -61.02% |
| Jun 30, 2020 | 184.01% |
| Mar 31, 2020 | 5,251.39% |
| Dec 31, 2019 | -97.36% |
| Sep 30, 2019 | 106.29% |
| Jun 30, 2019 | -371.83% |
| Mar 31, 2019 | -115.46% |
| Dec 31, 2018 | 1,323.73% |
| Sep 30, 2018 | -280.71% |
| Jun 30, 2018 | 332.76% |
| Mar 31, 2018 | -115.88% |